Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Amortizatization of Intangibles of $136000.0 for Q1 2026, down 52.78% sequentially from $288000.0 in Q4 2025, and down 85.8% YoY from $958000.0 in Q1 2025.
Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Amortizatization of Intangibles for 9 years, with the latest figure at $136000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 85.8% year-over-year to $136000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 74.09% YoY) and the FY2025 annual result came in at $2.5 million, down 69.4% from the prior year.
- Amortizatization of Intangibles slipped to $136000.0 in Q1 2026 per ADPT's latest filing, from $288000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $3.0 million in Q4 2023 and troughed at -$862000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.1 million in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles surged 756.45% in 2023, then tumbled 85.8% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at $1.1 million in 2022, then soared by 172.97% to $3.0 million in 2023, then tumbled by 50.73% to $1.5 million in 2024, then sank by 80.25% to $288000.0 in 2025, then plunged by 52.78% to $136000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $136000.0, $288000.0, and $516000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | - |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | - |
| 10 | Adaptive Biotechnologies | 3.78 Bn | 3.56 Bn | 52.17 Mn | 136,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136,000.00 |
| Mar 31, 2026 | 136,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Sep 30, 2025 | 516,000.00 |
| Sep 30, 2025 | 516,000.00 |
| Jun 30, 2025 | 750,000.00 |
| Jun 30, 2025 | 750,000.00 |
| Mar 31, 2025 | 958,000.00 |
| Mar 31, 2025 | 958,000.00 |
| Dec 31, 2024 | 1.46 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Dec 31, 2023 | 2.96 Mn |